Stock listing

Biophytis Sa

Selected listing: ALBPS · EURONEXT · EUR · FR

Biophytis Sa (Euronext:ALBPS), Health Technology. Latest release Sep 11, 2026: Biophytis S A : ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND…

ALBPS:EURONEXTEURFRUpdated October 2, 2026

Ticker: Euronext:ALBPS
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: Euronext
Currency: EUR

About Biophytis Sa

Biophytis SA is a public company traded on the French market under the ticker ALBPS. Biophytis focuses on developing innovative therapies for age-related diseases and conditions.

Latest news from Biophytis Sa

Biophytis S A : ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY

September 11, 2026

Biophytis S A : to evaluate BIO101’s potential to limit weight regain in its OBA clinical study in obesity

September 9, 2026

Biophytis S A : strengthens its financial position and extends its cash runway into Q1 2027

August 31, 2026

Biophytis S A : PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE

August 3, 2026

Biophytis S A : INFORMATION ON ANNUAL FINANCIAL STATEMENTS

April 29, 2026

All Biophytis Sa news →

Research Biophytis Sa

Biophytis Sa company profile

View the public company page for Biophytis Sa on 6ix.

Biophytis Sa news

Read company news and market updates connected to Biophytis Sa.

Biophytis Sa investor events

Find investor webinars, events, and replay context for Biophytis Sa.